Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CPRX - Catalyst Pharmaceuticals beats Q1 top and bottom line estimates; reaffirms FY23 outlook
May, 10 2023 04:38 PM
Catalyst Pharmaceuticals Inc.
2023-05-10 16:38:30 ET
Catalyst Pharmaceuticals press release ( NASDAQ: CPRX ): Q1 Non-GAAP EPS of $0.41 beats by $0.10 . Revenue of $85.4M (+98.2% Y/Y) beats by $3.78M . Cash and equivalents were $148.2 Million as of March 31, 2023. Affirms Full Year Total Revenue Guidance of Between $375 Million and $385 Million vs. consensus of $381.54M. Forecasts Full-Year 2023 Non-GAAP Net Income of Between $195 Million and $205 Million. For further details see:
Catalyst Pharmaceuticals beats Q1 top and bottom line estimates; reaffirms FY23 outlook
Stock Information
Company Name:
Catalyst Pharmaceuticals Inc.
Stock Symbol:
CPRX
Market:
NASDAQ
Website:
catalystpharma.com
Get CPRX Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .